Guoliang Zhang

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma

J. Ajani, K. Dalby, Wenliang Li, 2022, Journal of Experimental & Clinical Cancer Research.

A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression.

Zheng Wang, Wenliang Li, Tao Shen, 2023, Cancer letters.

Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST

Guoliang Zhang, Michael Bakhoum, Wenliang Li, 2023, Research square.

Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST

Guoliang Zhang, Michael Bakhoum, Wenliang Li, 2024, Cell death discovery.